Caplin Point Board Meeting on Aug 12, 2026 for Q1 Results & Dividend

Caplin Point Laboratories Ltd has announced a Board of Directors meeting scheduled for August 12, 2026. The primary agenda items include the consideration and approval of the unaudited financial results for the first quarter ended June 30, 2026 (standalone and consolidated). Additionally, the board will discuss the recommendation of a final dividend for the fiscal year 2025-26, the convening of the 35th Annual General Meeting, and the fixation of a record date for dividend eligibility. The company also reiterated its trading window closure for designated persons from July 1, 2026, to August 14, 2026.